Feb 20 (Reuters) - Cyclopharm Ltd (CYC) :
- RESOLVED TO PAY FINAL UNFRANKED DIVIDEND OF 0.5 AU CENTS PER SHARE
- FY PRELIMINARY REVENUES FROM ORDINARY ACTIVITIES UP 31.1% TO A$23.2 MILLION
- REMAINS CONFIDENT THAT EXPECTATIONS OF TRIAL RESULTS BEING PUBLISHED IN FIRST HALF OF 2023 WILL BE MET
- FY LOSS FOR THE YEAR A$6.6 MILLION VERSUS LOSS A$5.0 MILLION
- CONTINUES TO PROGRESS TOWARD ATTAINING USFDA APPROVAL TO COMMENCE COMMERCIAL SALES OF TECHNEGAS IN US MARKET IN 2023
- POISED TO ENTER ITS NEXT GROWTH PHASE IN 2023
News: CYC Cyclopharm Resolves To Pay Final Unfranked Dividend Of 0.5 AU Cents Per Share
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
-0.030(2.94%) |
Mkt cap ! $110.0M | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.03 | 99.0¢ | $178.1K | 178.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5020 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 125640 | 3 |
View Market Depth
| Last trade - 12.25pm 16/06/2025 (20 minute delay) ? |
| CYC (ASX) Chart |